Lataa...
Autoimmune Thyroid Disease Following Alemtuzumab Therapy and Hematopoietic Cell Transplantation in Pediatric Patients with Sickle Cell Disease
Allogenic hematopoietic cell transplantation (alloHCT) is currently the only curative treatment option for patients with sickle cell disease. Alemtuzumab is a monoclonal antibody directed against CD52 positive cells used in myeloablative conditioning regimens for alloHCT. Its use has been associated...
Tallennettuna:
| Julkaisussa: | Pediatr Blood Cancer |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4440678/ https://ncbi.nlm.nih.gov/pubmed/24938636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25102 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|